EÇErkan Çelik

Erkan Çelik

*This is an algorithmically generated author record based on publicly available information.

Erkan Çelik has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Subfoveal Choroidal Thickness in Clinically Significant Pseudophakic Cystoid Macular Edema: An Interocular Comparison with Contralateral Pseudophakic Eyes

    by Kadriye Demir, Erkan Çelik

    Purpose: To evaluate subfoveal choroidal thickness (SCT) in eyes with clinically significant pseudophakic cystoid macular edema (PCME) and compare it with the contralateral pseudophakic eyes that underwent uncomplicated cataract surgery within a similar postoperative period using enhanced depth imaging optical coherence tomography (EDI-OCT). Methods: This retrospective observational study included 25 patients with clinically significant PCME following uneventful phacoemulsification and posterior chamber intraocular lens implantation. The control group consisted of contralateral pseudophakic eyes that had undergone uncomplicated cataract surgery within one month of the affected eye and did not develop PCME. SCT and central macular thickness (CMT) were measured using spectral-domain OCT with EDI mode. Best-corrected visual acuity (BCVA), age, and sex were recorded. Paired comparisons were performed between PCME eyes and pseudophakic fellow eyes to minimize the confounding effect of surgery-related choroidal changes. Results: The mean age of the patients was 66.13 ± 5.44 years (range, 59– 77). 14 (56%) were male and 11 (44%) were female. The mean interval between cataract surgery and PCME diagnosis was 6.2 ± 1.6 weeks. The mean CMT was significantly higher in PCME eyes (458.20 ± 92.30 μm) compared with pseudophakic fellow eyes (235.66 ± 28.43 μm, p < 0.001). The mean SCT was 297.27 ± 24.52 μm in PCME eyes and 289.41 ± 22.16 μm in pseudophakic fellow eyes. Although SCT was numerically greater in PCME eyes, the difference did not reach statistical significance (p = 0.18). Conclusion: SCT was slightly higher in eyes with PCME compared to contralateral pseudophakic eyes operated within a similar postoperative period; however, the difference was not statistically significant, which may partly be related to the limited sample size. These findings suggest that choroidal thickening observed in PCME may largely reflect postoperative inflammatory changes rather than a disease-specific choroidal mechanism.

  • Open Access

    Comparative outcomes of posterior sub-Tenon triamcinolone for pseudophakic cystoid macular edema in diabetic and non-diabetic patients: a retrospective study

    by Kadriye Demir, Erkan Çelik

    To compare the anatomical and functional outcomes of posterior sub-Tenon triamcinolone (PST) in the treatment of pseudophakic cystoid macular edema (PCME)

  • Open Access

    Impact of phacoemulsification on choroidal and ganglion cell complex thickness assessed by spectral-domain optical coherence tomography

    by Kadriye Demir, Erkan Çelik

    Aims: To investigate the effects of phacoemulsification on subfoveal choroidal thickness (SFCT) and ganglion cell complex thickness (GCCT), using spectral-domain optical coherence tomography (SD-OCT). Methods: This retrospective study included 40 eyes of 40 patients who underwent phacoemulsification with intraocular lens implantation for senile cataract. Preoperative examinations included best-corrected visual acuity (BCVA), slit-lamp biomicroscopy, intraocular pressure (IOP), central corneal thickness (CCT), and axial length (AL). Operative time (OT) and effective phaco time (EPT) were recorded. SFCT, GCCT, central macular thickness (CMT), and peripapillary retinal nerve fiber layer thickness (pRNFLT) were measured preoperatively and at 1 month using SD-OCT. Results: At one month postoperatively, all parameters showed statistically significant increases (p<0.001): SFCT (298.6±41.3 µm to 304.6±40.8 µm), GCCT (83.2±4.4 µm to 91.4±6.1 µm), CMT (244.6±16.6 µm to 248.3±17.4 µm), and pRNFLT (95.3±5.1 µm to 100.9±5.8 µm). No significant associations were found between changes in SFCT or GCCT and demographic or clinical factors. Conclusion: Phacoemulsification may induce mild inflammatory changes that affect posterior segment structures, even in uneventful cases. SFCT, GCCT, CMT, and pRNFLT should therefore be re-evaluated postoperatively to establish new baselines for accurate monitoring. Larger, long-term studies are warranted to clarify the clinical relevance of these changes.

  • Open Access

    Comparison of the Effects of the Ketogenic Diet and Western Diet on the Retina in Rats with Diabetes

    by Halil İbRahim Sönmezoğlu, İsa Yuvacı, Nureddin Cengiz, Büşra Güner Sönmezoğlu, Gökhan Oturak, Erkan Çelik

    Objective: This study aimed to investigate the effects of different diets on the retina in rats with diabetes mellitus (DM). Materials and Methods: In our study, a total of 4 groups were formed: healthy and regular diet (Group 1), DM-induced and regular diet (Group 2), DM-induced and ketogenic diet (KD) (Group 3), DM-induced and western diet (WD) (Group 4). Tissue sections were histo-scored using Vascular endothelial growth factor (VEGF) and Caspase-3 immunohistochemical staining method. The thicknesses of the retinal layers stained with hematoxylin-eosin were compared. Results: Retinal staining with VEGF revealed a greater incidence of low-intensity staining in Group 3 (p: 0.018). There was no notable disparity observed across the groups in the staining of the retinas with Caspase-3 (p: 0.65). When the thicknesses of the retinal layers were compared, it was observed that the inner-outer nuclear, inner plexiform and ganglion layers were significantly thicker in the WD group than the other groups (p values

  • Evaluation of the effect of vitreomacular interface disorders on anti-VEGF treatment in patients with diabetic macular edema in real life: MARMASIA study group report No. 10

    by Erdinç Bozkurt, Fatih Bilgehan Kaplan, Ecem Önder Tokuç, Aslan Aykut, Işılay Özsoy Saygın, Hatice Selen Kanar, Işıl Kutlutürk, Mehmet Orkun Sevik, Uğur Yayla, Erkan Çelik, et al.

    Purpose The aim of this study is to investigate the effect of vitreomacular interface disorders (VMID) on treatment response in patients treated with anti-vascular endothelial growth factor (anti-VEGF) due to diabetic macular edema (DME). Methods Three hundred seventy-seven eyes of 239 patients in the MARMASIA Study Group who received intravitreal anti-VEGF treatment (IVT) due to DME were included in the study. The group 1 consisted of 44 eyes of the patients who had not received any treatment before, were followed up regularly for 24 months after at least a 3-month loading dose, and suffered from VMID such as epiretinal membrane, vitreomacular adhesion or traction, and lamellar hole. The group 2 consisted of 333 eyes of the patients without VMID. Best-corrected visual acuity (BCVA) and central macular thickness (CMT) of the patients at baseline, 3rd month, 6th month, 1st year and 2nd year follow-ups were measured. Results The mean age of the Groups 1 and 2 was 67.1 ± 11.3 and 61.9 ± 10.2 years, respectively. 61.3% of the group 1 and 58.8% of the group 2 were female (p > 0.05). The duration of diabetes was 19.2 ± 3.7 and 15.8 ± 3.2 years, respectively, and the number of follow-ups was 16.09 ± 4.68 and 12.06 ± 4.58, respectively in the groups (p < 0.001, 0.001, respectively). The number of IVT was 7.13 ± 2.71 and 7.20 ± 2.22, respectively in the groups 1 and 2 and no statistically significant difference was observed between them (p = 0.860). According to logMAR, BCVA values at baseline were 0.63 ± 0.24 and 0.59 ± 0.26 (p = 0.29), respectively, in the groups and the amount of change in BCVA at the end of the 2nd year was − 0.02 ± 0.48 in the group 1 and − 0.12 ± 0.48 in the group 2. It was observed as 0.48 (p = 0.13). Although the increase in BCVA was greater at all follow-ups in the group 2 compared to their initial examination, no significant difference was observed between the groups in terms of BCVA change. The CMT values of the groups at baseline were 442.5 ± 131.3 µm and 590.9 ± 170.6 µm, respectively (p = 0.03) The decrease in CMT after IVT was significantly greater in the group 2 at all follow-ups when compared to the first group (p < 0.05). Conclusion While the presence of VMID in DME patients receiving IVT did not affect visual results, it negatively affected the anatomical response and macular edema morphology. The presence of VMID at baseline affected the success of IVT. It should be taken into consideration that VMID may resolve spontaneously or with IVT, and new cases of VMID may occur in patients during the treatment process.


  • One-Year Functional and Morphological Prognosis After Intravitreal Injection Treatments According to Different Morphological Patterns of Diabetic Macular Edema in Real-Life: MARMASIA Study Group Report No.13

    by Utku Limon, Fatih Bilgehan Kaplan, Işılay Saygın, Ecem Önder Tokuç, Işıl Kutlutürk Karagöz, Hatice Selen Kanar, Mehmet Orkun Sevik, Uğur Yayla, Erkan Çelik, Ayşe Sönmez, et al.

    To evaluate the responses of different optical coherence tomography (OCT) patterns of diabetic macular edema (DME) to intravitreal injection therapy. In this retrospective, comparative, and multicenter study, patients who had previously untreated DME, who received intravitreal ranibizumab (IVR) or aflibercept (IVA) and/or steroid treatment with the pro re nata (PRN) treatment regimen after a 3-month loading dose, and had a 12-month follow-up in the MARMASIA Study Group were included. Morphological patterns of DME were divided into four groups based on OCT features diffuse/spongious edema (Group 1), cystoid edema (Group 2), diffuse/spongious edema+subretinal fluid (SRF) (Group 3), and cystoid edema+SRF (Group 4). Changes in central macular thickness (CMT) and best-corrected visual acuity (BCVA) at months 3, 6, and 12, and the number of injections at month 12 were compared between the DME groups. 455 eyes of 299 patients were included in the study. The mean baseline BCVAs [Logarithm of the Minimum Angle of Resolution (logMAR)] in groups 1, 2, 3, and 4 were 0.54 ± 0.24, 0.52 ± 0.25, 0.55 ± 0.23, and 0.57 ± 0.27, respectively. There was no significant difference between the baseline mean BCVAs between the groups (p = .35). The mean BCVAs were significantly improved to 0,47 ± 0,33 in group 1, 0,42 ± 0,33 in group 2, 0,47 ± 0,31 in group 3, and 0,45 ± 0,43 at month 12. There was no significant difference between the groups in terms of BCVA change at month 12 (p = .71). The mean baseline CMTs in groups 1, 2, 3, and 4 were 387,19 ± 128,19, 447,02 ± 132,39, 449,12 ± 109,24, and 544,19 ± 178,61, respectively. At baseline, the mean CMT was significantly higher in Group 4 than in the other groups (p = .000). The mean CMTs were significantly decreased to 325,16 ± 97,55, 334,94 ± 115,99, 324,33 ± 79,20, and 332,08 ± 150,40 in four groups at month 12 respectively (p > .05). The groups had no significant difference in mean CMT at month 12 (p = .835). The change in CMT was significantly higher in Group 4 than in the other groups at month 12 (p = .000). The mean number of intravitreal anti-VEGF injections at month 12 was 4.51 ± 1.57 in Group 1, 4.63 ± 1.54 in Group 2, 4.88 ± 1.38 in Group 3, and 5.07 ± 1.49 in Group 4. The mean number of anti-VEGF injections in Group 1 and Group 2 was significantly lower than in Group 4 (p = 0,014 and p = 0,017). In real life, there was no significant difference between the DME groups in terms of visual improvement at month 12. However, better anatomical improvement was achieved in Group 4 than in the other DME groups.


  • Open Access

    Real-World Outcomes of Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in Türkiye: MARMASIA Study Group Report No. 1

    by Uğur Yayla, Mehmet Orkun Sevik, Veysel Levent Karabaş, Özlem Şahin, Abdullah Özkaya, Nursal Melda Yenerel, Banu Açıkalın Öncel, Fatih Bilgehan Kaplan, Ecem Önder Tokuç, Hatice Selen Kanar, et al.

    This study aimed to report the demographic and clinical characteristics of diabetic macular edema (DME) patients treated with intravitreal injection (IVI) of anti-vascular endothelial growth factors (anti-VEGF) and provide an overview of outcomes during routine clinical practice in Türkiye. This retrospective, real-world study included 1,372 eyes (854 patients) treated with a pro re nata protocol by 21 ophthalmologists from 8 tertiary clinics on the Asian side of the Marmara region of Türkiye (MARMASIA Study Group). Five cohort groups were established by collecting the patients' baseline and 3, 6, 12, 24, and 36-month follow-up data, where each subsequent cohort may include the previous. Changes in best-corrected visual acuity (BCVA, approximate ETDRS letters) and central macular thickness (CMT, μm), number of visits and IVI, and rates of anti-VEGF switch and intravitreal dexamethasone implant (IDI) combination were evaluated. The 3, 6, 12, 24, and 36-month cohorts included 1372 (854), 1352 (838), 1185 (722), 972 (581), and 623 (361) eyes (patients), respectively. The mean baseline BCVA and CMT were 51.4±21.4 letters and 482.6±180.3 μm. The mean changes from baseline in BCVA were +7.6, +9.1, +8.0, +8.6, and +8.4 letters, and in CMT were -115.4, -140.0, -147.9, -167.3, and -215.4 μm at the 3, 6, 12, 24, and 36-month visits (p<0.001 for all). The median cumulative number of anti-VEGF IVI was 3.0, 3.0, 5.0, 7.0, and 9.0, respectively. The overall anti-VEGF switch and IDI combination rates were 18.5% (253/1372 eyes) and 35.0% (480/1372 eyes), respectively. This largest real-life study of DME from Türkiye demonstrated BCVA gains inferior to randomized controlled trials, mainly due to the lower number of IVI. However, with the lower baseline BCVA and higher IDI combination rates in our cohorts, these gains were relatively superior to other real-life study counterparts.


  • Retinal nerve fiber layer and ganglion cell complex thickness in diabetic smokers without diabetic retinopathy

    by Kübra Özata Gündoğdu, Emine Doğan, Erkan Çelik, Gürsoy Alagöz

    PurposeTo compare the thickness of the retinal nerve fiber layer (RNFL) and macular ganglion cell-inner plexiform layer (GC-IPL) in smoker and nonsmoker diabetics without diabetic retinopathy.Materials and MethodsPatients with diabetes were divided into two groups according to their smoking status: Group 1 consisted of 38 smoker diabetics who had chronically smoked more than 20 cigarettes per day for more than five years; Group 2 consisted of 38 nonsmoker diabetics. After a detailed ophthalmologic examination, the mean and regional (superior, supratemporal, inferior, inferotemporal, temporal, nasal, superonasal, and inferonasal) RNFL and GC-IPL thicknesses were measured with spectral-domain optic coherence tomography (SD-OCT) and compared between groups.ResultsThe mean age was 54.7 +/- 10.5 and 51.2 +/- 9.7 years in the smoker and nonsmoker groups, respectively (p = 0.14). Gender, duration of diabetes, and the mean axial length were similar between groups (p:0.43, p:0.54, p: 0.52, respectively). Mean RNFL thickness was 89.1 +/- 8.0 mu m in the smoker group and 93.4 +/- 7.0 mu m in the nonsmoker group, and it was significantly thinner in the smoker group (p = 0.01). The temporal RNFL thickness in the smoker group was thinner than in the nonsmoker group (p = 0.02). There was no difference in superior, inferior, and nasal RNFL thicknesses between the groups (p = 0.31, p = 0.12, p = 0.39, respectively). The mean macular GC-IPL thickness of the smoker and nonsmoker groups was 78.53 +/- 15.74 mu m and 83.08 +/- 5.85 mu m, respectively (p = 0.09). Superior, superonasal, inferonasal, inferior, inferotemporal, and superotemporal quadrant GC-IPL thicknesses were similar between the groups (p = 0.07, p = 0.60, p = 0.55, p = 0.77, p = 0.71, p = 0.08, respectively). The groups showed no difference in minimum GC-IPL thickness (p = 0.43). There was a significant negative correlation between smoking exposure and mean, inferior quadrant RNFL thicknesses in the smoker group (p = 0.04, r= -0.32, and p = 0.01, r= -0.39, respectively).ConclusionMean RNFL thickness was significantly thinner in smoker diabetics. Although not statistically significant, especially mean, superior, and superotemporal GC-IPL was thinner in smoker diabetics. The results suggest a potential association between the coexistence of diabetes and smoking with alterations in RNFL and GC-IPL thickness.


  • Open Access

    Travmatik Hifemada Klinik ve Görsel Prognoza Etki Eden Faktörler

    by Özlem Bursali, Emine Doğan, Nilgün Özkan, Şule Bahadir Coşkun, Erkan Çeli̇k, Gürsoy Alagöz

    Amaç: Travmatik hifema nedeniyle takip edilen olgularda demografik ve klinik özelliklerin incelenmesi ve görsel prognoza etki eden faktörlerin değerlendirilmesi Gereç -Yöntem: Travmatik hifema tanısıyla takip edilen 48 hastanın dosyaları geriye dönük olarak taranarak; yaş, cinsiyet, yaralanma nedeni, hifema düzeyi, başlangıç en iyi düzeltilmiş görme keskinliği (EİDGK), eşlik eden klinik bulgular, son muayenedeki EİDGK incelendi. EİDGK’ne etki eden prognostik faktörler incelendi. Bulgular: Hastaların (38 erkek,10 kadın) yaş ortalaması 39.5±21.6 yıl olup; en sık travma nedeni odun çarpmasına bağlı künt travma (%25) idi. Hifema düzeyi değerlendirildiğinde en sık Evre 1(%41.66) hifema mevcuttu. Travmaya eşlik eden bulgular; 23 gözde (%47.91) kornea epitel defekti,11 gözde (%22.91) iridodiyaliz, 7 gözde (%14,58) fakodonezis,10 gözde (%20.83) vitreus hemorajisi idi. Başvuru anında 35 gözde göz içi basıncı (GİB) yüksek olup medikal tedavi ile kontrol altına alındı, 3 gözde ön kamara lavajı yapılması gerekti. Hastaların başlangıç,1.hafta ve 3.ay EİDGK sırasıyla 1.7 ±0.8; 0.5±0.5; 0.2±0.3 (LogMAR )idi. Hastaların 4’üne ek cerrahi işlem (lens ekstraksiyonu + göz içi mercek implantasyonu ve/veya vitreoretinal cerrahi) gerekti. İridodiyaliz (p=0,023 r= -0,345), fakodonezis (p=0,020,r= -0,347) ve vitreus hemorajisi (p=0,000, r= -0,553) varlığı ile son görme düzeyi arasında negatif korelasyon mevcuttu. Tartışma: Travmatik hifemaya sıklıkla çeşitli ön- arka segment bulguları eşlik etmekte olup; iridodiyaliz, fakodonezis ve vitreus hemorajisi varlığı görme prognozunu olumsuz etkilemektedir.

  • Effects of glaucoma and central corneal thickness on optic nerve head biomechanics

    by Nilgün Özkan Aksoy, Burçin Çakır, Yakup Ersel Aksoy, Kadriye Demir Boncukçu, Sedat Özmen, Erkan Çelik, Gürsoy Alagöz

    Purpose To evaluate effects of glaucoma and central corneal thickness (CCT) on optic nerve head biomechanics. Methods Four groups were formed according to CCT measurements and the presence of glaucoma. Glaucomatous patients with thin (< 510 µ) and thick (> 570 µ) corneas composed groups 1 and 3, respectively. Nonglaucomatous patients with thin and thick corneas composed groups 2 and 4, respectively. Real-time elastography (RTE) was performed on all groups, and optic nerve strain rate (ONSR), orbital fat strain rate (OFSR), and strain ratio of orbital fat to the optic nerve and medial and lateral parts of the optic nerve (SROFON, SROFMON, SROFLON, respectively) were obtained and compared between groups. The correlations between CCT and these parameters were also investigated. Results Statistically significant difference was not found between groups in terms of strain rate of optic nerve and orbital fat, SRFON, SROFMON and SROFLON. There was a positive correlation between ONSR and OFSR and mean CCT in patients with CCT thinner than 510 µ (p: 0.03 r: 0.26, p: 0.01 r: 0.32 respectively). Conclusion SROFON, SROFLON and SROFMON values did not differ between glaucomatous and nonglaucomatous patients with thin or thick CCTs. The correlations between CCT and OFSR and ONSR were found to be statistically significant in patients with thin CCT.